Literature DB >> 21898345

Evidence of the contribution of the X chromosome to systemic sclerosis susceptibility: association with the functional IRAK1 196Phe/532Ser haplotype.

P Dieudé1, M Bouaziz, M Guedj, G Riemekasten, P Airò, M Müller, D Cusi, M Matucci-Cerinic, I Melchers, W Koenig, E Salvi, H E Wichmann, G Cuomo, E Hachulla, E Diot, N Hunzelmann, P Caramaschi, L Mouthon, V Riccieri, J Distler, I Tarner, J Avouac, O Meyer, A Kahan, G Chiocchia, C Boileau, Y Allanore.   

Abstract

OBJECTIVE: Several autoimmune disorders, including systemic sclerosis (SSc), are characterized by a strong sex bias. To date, it is not known whether genes on the sex chromosomes influence SSc susceptibility. Recently, an IRAK1 haplotype that contains the 196Phe functional variant (rs1059702), located on Xq28, was found to confer susceptibility to systemic lupus erythematosus (SLE). This study was undertaken to test for an association between SSc and the IRAK1 SLE risk haplotype.
METHODS: We tested for an association with the IRAK1 SLE risk haplotype in a discovery set of 849 SSc patients and 625 controls. IRAK1 rs1059702 was further genotyped in a replication set, which included Caucasian women from Italy (493 SSc patients and 509 controls) and Germany (466 SSc patients and 1,083 controls).
RESULTS: An association between the IRAK1 haplotype and SSc was detected in the discovery set. In both the discovery and replication sets, the rs1059702 TT genotype was found to be associated with specific SSc subsets, highlighting a potential contribution to disease severity. A meta-analysis provided evidence of an association of both the T allele and TT genotype with the overall disease, with an odds ratio (OR) of 1.20 and 95% confidence interval (95% CI) of 1.06-1.35 for the T allele (P = 0.003) and an OR of 1.49 and 95% CI of 1.06-2.10 for the TT genotype (P = 0.023). However, the most notable associations were observed with the diffuse cutaneous, anti-topoisomerase I antibody positive, and SSc-related fibrosing alveolitis subsets (OR 2.35 [95% CI 1.51-3.66], P = 1.56 × 10(-4), OR 2.84 [95% CI 1.87-4.32], P = 1.07 × 10(-6), and OR 2.09 [95% CI 1.35-3.24], P = 9.05 × 10(-4), respectively).
CONCLUSION: Our study provides the first evidence of an association between IRAK1 and SSc, demonstrating that a sex chromosome gene directly influences SSc susceptibility and its phenotypic heterogeneity.
Copyright © 2011 by the American College of Rheumatology.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21898345     DOI: 10.1002/art.30640

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  28 in total

1.  Identification of an Association of TNFAIP3 Polymorphisms With Matrix Metalloproteinase Expression in Fibroblasts in an Integrative Study of Systemic Sclerosis-Associated Genetic and Environmental Factors.

Authors:  Peng Wei; Yang Yang; Xinjian Guo; Nainan Hei; Syeling Lai; Shervin Assassi; Mengyuan Liu; Filemon Tan; Xiaodong Zhou
Journal:  Arthritis Rheumatol       Date:  2016-03       Impact factor: 10.995

Review 2.  The sex bias in systemic sclerosis: on the possible mechanisms underlying the female disease preponderance.

Authors:  Fabio D'Amico; Evangelia Skarmoutsou; Maria Clorinda Mazzarino
Journal:  Clin Rev Allergy Immunol       Date:  2014-12       Impact factor: 8.667

Review 3.  Personalized medicine in systemic sclerosis: facts and promises.

Authors:  Rucsandra Dobrota; Carina Mihai; Oliver Distler
Journal:  Curr Rheumatol Rep       Date:  2014-06       Impact factor: 4.592

4.  Association of interleukin-1 receptor-associated kinase (IRAK1) gene polymorphisms (rs3027898, rs1059702) with systemic lupus erythematosus in a Chinese Han population.

Authors:  Yu Zhai; Ke Xu; Rui-Xue Leng; Han Cen; Wei Wang; Yan Zhu; Mo Zhou; Chen-Chen Feng; Dong-Qing Ye
Journal:  Inflamm Res       Date:  2013-02-23       Impact factor: 4.575

Review 5.  Pathogenesis of Systemic Sclerosis.

Authors:  Debendra Pattanaik; Monica Brown; Bradley C Postlethwaite; Arnold E Postlethwaite
Journal:  Front Immunol       Date:  2015-06-08       Impact factor: 7.561

6.  Fine mapping of Xq28: both MECP2 and IRAK1 contribute to risk for systemic lupus erythematosus in multiple ancestral groups.

Authors:  Kenneth M Kaufman; Jian Zhao; Jennifer A Kelly; Travis Hughes; Adam Adler; Elena Sanchez; Joshua O Ojwang; Carl D Langefeld; Julie T Ziegler; Adrienne H Williams; Mary E Comeau; Miranda C Marion; Stuart B Glenn; Rita M Cantor; Jennifer M Grossman; Bevra H Hahn; Yeong Wook Song; Chack-Yung Yu; Judith A James; Joel M Guthridge; Elizabeth E Brown; Graciela S Alarcón; Robert P Kimberly; Jeffrey C Edberg; Rosalind Ramsey-Goldman; Michelle A Petri; John D Reveille; Luis M Vilá; Juan-Manuel Anaya; Susan A Boackle; Anne M Stevens; Barry I Freedman; Lindsey A Criswell; Bernardo A Pons Estel; Joo-Hyun Lee; Ji-Seon Lee; Deh-Ming Chang; R Hal A Scofield; Gary S Gilkeson; Joan T Merrill; Timothy B Niewold; Timothy James Vyse; Sang-Cheol Bae; Marta E Alarcón-Riquelme; Chaim O Jacob; Kathy Moser Sivils; Patrick M Gaffney; John B Harley; Amr H Sawalha; Betty P Tsao
Journal:  Ann Rheum Dis       Date:  2012-08-17       Impact factor: 19.103

Review 7.  The genetics of scleroderma: looking into the postgenomic era.

Authors:  Maureen D Mayes
Journal:  Curr Opin Rheumatol       Date:  2012-11       Impact factor: 5.006

Review 8.  The status of pulmonary fibrosis in systemic sclerosis is associated with IRF5, STAT4, IRAK1, and CTGF polymorphisms.

Authors:  Wenjie Zhao; Xiaoyang Yue; Kuai Liu; Junfeng Zheng; Runda Huang; Jun Zou; Gabriela Riemekasten; Frank Petersen; Xinhua Yu
Journal:  Rheumatol Int       Date:  2017-04-22       Impact factor: 2.631

9.  New insight on the Xq28 association with systemic sclerosis.

Authors:  F David Carmona; M Carmen Cénit; Lina-Marcela Diaz-Gallo; Jasper C A Broen; Carmen P Simeón; Patricia E Carreira; José-Luis Callejas-Rubio; Vicente Fonollosa; Francisco J López-Longo; Miguel A González-Gay; Nicolas Hunzelmann; Gabriela Riemekasten; Torsten Witte; Alexander Kreuter; Jörg H W Distler; Rajan Madhok; Paul Shiels; Jacob M van Laar; Annemie J Schuerwegh; Madelon C Vonk; Alexandre E Voskuyl; Carmen Fonseca; Christopher P Denton; Ariane Herrick; Jane Worthington; Frank C Arnett; Filemon K Tan; Shervin Assassi; Timothy R D J Radstake; Maureen D Mayes; Javier Martín
Journal:  Ann Rheum Dis       Date:  2013-02-26       Impact factor: 19.103

Review 10.  Genetics of scleroderma: implications for personalized medicine?

Authors:  Shervin Assassi; Timothy R D J Radstake; Maureen D Mayes; Javier Martin
Journal:  BMC Med       Date:  2013-01-11       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.